U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076379
Company: PADAGIS US

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE EQ 2MG BASE/ML SYRUP;ORAL Prescription AA No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/02/2005 ORIG-1 Approval

Label is not available on this site.
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/17/2023 SUPPL-11 Labeling-Package Insert

Label is not available on this site.
04/27/2017 SUPPL-8 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.
04/27/2017 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

MIDAZOLAM HYDROCHLORIDE

SYRUP;ORAL; EQ 2MG BASE/ML
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE EQ 2MG BASE/ML SYRUP;ORAL Prescription No AA 075873 HIKMA
MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE EQ 2MG BASE/ML SYRUP;ORAL Prescription No AA 076379 PADAGIS US
Back to Top